<?xml version="1.0" encoding="UTF-8"?>
<p> The antibody response to smallpox vaccination is known to play a crucial role in the protection against a subsequent viral infection [
 <xref rid="R8" ref-type="bibr">8</xref>, 
 <xref rid="R9" ref-type="bibr">9</xref>, 
 <xref rid="R20" ref-type="bibr">20</xref>]. Reliable protection against a smallpox infection was shown to be provided at a virus-neutralizing antibody titer in the blood serum of vaccinated people above 1:32 [
 <xref rid="R21" ref-type="bibr">21</xref>]. In humoral immunity defects, vaccination may not provide smallpox protection. In a B-cell-deficient mouse model, animals were shown not to be able to withstand ECTV re-infection despite noticeable activity of antiviral CD8
 <sup>+</sup> T cells [
 <xref rid="R22" ref-type="bibr">22</xref>]. 
</p>
